IMPACT NEWS
Spotlight on health pioneers
discover the newest testimonial film from our start-up community
Isospec Analytics SA
Revealing the Hidden Biology of Disease – Advancing Diagnostics and Drug Development
In this video, Ahmed Ben Faleh, CEO & Co-Founder, Dr. Stephan Warnke, CTO & Co-Founder and Dr. Thomas Rizzo, CSO & Co-Founder of Isospec Analytics SA share their vision of uncovering hidden biomarker data to enable earlier diagnosis, better disease understanding, and more personalized treatments.
Isospec Analytics is developing a breakthrough technology platform to identify biomarker data that remains invisible to conventional methods. By combining mass spectrometry and infrared spectroscopy, the company can detect difficult-to-identify molecules and hidden sugar profiles in patient samples, distinguishing between molecules that may appear identical with traditional technologies but have very different biological functions. This innovative approach helps researchers better understand complex diseases such as cardiovascular disease, cancer, and Alzheimer’s, while enabling earlier diagnosis, better risk prediction, more accurate patient stratification, and improved matching of patients with the right therapies.
